reference/13272614

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13272614

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	1638
issn	1557-3265 1078-0432
issueIdentifier	5
pageRange	1630-1638
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1630
bibliographicCitation	Amino N, Ideyama Y, Yamano M, Kuromitsu S, Tajinda K, Samizu K, Hisamichi H, Matsuhisa A, Shirasuna K, Kudoh M, Shibasaki M. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors. Clin Cancer Res. 2006 Mar 01;12(5):1630–8. doi: 10.1158/1078-0432.ccr-05-2028. PMID: 16533791.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5914738368e8313340f4e1b3568fdb7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c852f61eca3788c26ce22b7a42e4810c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efda832686d265107feb295920a940ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edae7320c080bf58c72393cf81992303 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76b4e122c8eced101e7db91d3c9bbfa9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e82f051fc8296b222090afa751a6e501 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a4096fd994abd72dadd8c5b6ec1a837 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9883adbf72273362e5807abd442fbe6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c40d2ffe4102de0b22fdd15c0f5e8679 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_911c23fe27d75a3ac8f8d6330cd98cb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20b5340a1ec01e135063a4f270de39d2
date	2006-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16533791 https://doi.org/10.1158/1078-0432.ccr-05-2028
isPartOf	https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0441463 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0497618 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0185196 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0441459 http://id.nlm.nih.gov/mesh/M0001486 http://id.nlm.nih.gov/mesh/M0444984 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0356369
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020533Q000627 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D040301Q000037 http://id.nlm.nih.gov/mesh/D013844Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D017239Q000627 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D040301Q000378 http://id.nlm.nih.gov/mesh/D000077156 http://id.nlm.nih.gov/mesh/D000972Q000627 http://id.nlm.nih.gov/mesh/D009369Q000098 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008813 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D009369Q000473 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D042461Q000378 http://id.nlm.nih.gov/mesh/D042461Q000037 http://id.nlm.nih.gov/mesh/D001682 http://id.nlm.nih.gov/mesh/D009389Q000517 http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D009389Q000188 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D015394
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9933475 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8625 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135421289 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9811611 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3791 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247423804 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629

Total number of triples: 95.